JPH02272084A - Aerosol product for application to human body - Google Patents
Aerosol product for application to human bodyInfo
- Publication number
- JPH02272084A JPH02272084A JP1093395A JP9339589A JPH02272084A JP H02272084 A JPH02272084 A JP H02272084A JP 1093395 A JP1093395 A JP 1093395A JP 9339589 A JP9339589 A JP 9339589A JP H02272084 A JPH02272084 A JP H02272084A
- Authority
- JP
- Japan
- Prior art keywords
- aerosol
- diameter
- product
- alcohol
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 91
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 48
- 239000000203 mixture Substances 0.000 claims abstract description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 24
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 23
- 239000004480 active ingredient Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 238000005507 spraying Methods 0.000 abstract description 5
- 239000007789 gas Substances 0.000 description 46
- 235000019441 ethanol Nutrition 0.000 description 21
- 239000007921 spray Substances 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- 239000003380 propellant Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 6
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000001166 anti-perspirative effect Effects 0.000 description 4
- 239000003213 antiperspirant Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- -1 fluorocarbons Substances 0.000 description 3
- 239000003595 mist Substances 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000035597 cooling sensation Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000003915 liquefied petroleum gas Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000013842 nitrous oxide Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
- 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/32—Dip-tubes
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、炭酸ガスを噴射剤として用いた人体塗布用エ
アゾール製品に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to an aerosol product for application to the human body using carbon dioxide gas as a propellant.
〔従来技術と発明が解決しようとする課題〕従来エアゾ
ール組成物の噴射剤としては、主にフロン、液化石油ガ
ス、ジメチルエーテル(DME)等の液化ガスが使用さ
れていた。[Prior Art and Problems to be Solved by the Invention] Conventionally, liquefied gases such as fluorocarbons, liquefied petroleum gas, and dimethyl ether (DME) have been mainly used as propellants for aerosol compositions.
これら液化ガスを噴射剤として用いた人体塗布用エアゾ
ール製品は、噴射圧力を一定に保持できるので、製品使
用開始時から終わりまで常に一定した噴霧状態を得るこ
とができる。また噴射される液は、バルブのノズルによ
って液…が破砕されると同時に液化ガスの急激な膨張で
細かく均一な粒子として噴霧することができる。更にエ
アゾール組成物中に含まれる液化ガスの一部か体表で気
化するので清涼感が得られる。Aerosol products for application to the human body that use these liquefied gases as propellants can maintain a constant spray pressure, so that a constant spray state can be obtained from the beginning to the end of product use. In addition, the liquid to be injected can be atomized into fine, uniform particles by the rapid expansion of the liquefied gas at the same time as the liquid is crushed by the nozzle of the valve. Furthermore, a portion of the liquefied gas contained in the aerosol composition evaporates on the body surface, providing a refreshing feeling.
ところが、反面、液化ガスは価格が割高であるうえに、
所望の噴射圧力を得るには多量に配合する必要があるの
でエアゾール製品の材料コストが高騰する不満がある。However, on the other hand, liquefied gas is expensive and
In order to obtain the desired injection pressure, it is necessary to blend a large amount, which causes dissatisfaction with the rising cost of materials for aerosol products.
また液化ガスによって得られろ噴射圧力は温度依存性が
大きいので、このエアゾール製品は、温度により噴射状
聾が大幅に変化する欠点かある。Furthermore, since the injection pressure obtained with liquefied gas is highly temperature dependent, this aerosol product has the disadvantage that the injection pressure varies significantly depending on the temperature.
一方、このような欠点の少ない噴射剤として、炭酸ガス
、窒素ガス、笑気ガス、空気等を圧縮した圧縮ガスが知
られている。圧縮ガスを噴射剤とした人体塗布用エアゾ
ール製品は、価格が安く、噴射圧力の温度依存性が小さ
い。On the other hand, compressed gases obtained by compressing carbon dioxide gas, nitrogen gas, laughing gas, air, etc. are known as propellants with few such drawbacks. Aerosol products for human body application that use compressed gas as a propellant are inexpensive and have little temperature dependence on injection pressure.
しかしながら、圧縮ガスを噴射剤として用いた従来の人
体塗布用エアゾール製品は、噴射時にエアゾール組成物
が破砕され難く、湿っぽかったり勢いがなかったする問
題があった。また清涼感にも乏j2い問題があった。However, conventional aerosol products for application to the human body that use compressed gas as a propellant have problems in that the aerosol composition is difficult to break up during injection, resulting in a wet or lackluster feel. There was also the problem of a lack of refreshing sensation.
本発明は上記事情に鑑みてなされたもので、安価に製造
できるうえに、噴霧特性が良(かつ清涼感に富む人体塗
布用エアゾール製品を提供することを目的とする。The present invention was made in view of the above circumstances, and an object of the present invention is to provide an aerosol product for application to the human body that can be manufactured at low cost, has good spray characteristics (and has a refreshing feeling).
本発明の人体塗布用エアゾール製品は、■炭素数1〜3
のアルコール 55重1%以下■20°Cで蒸気圧が0
.8〜5 kg/amNGの液化ガス 45〜95重量
%
■炭酸ガス 0.2〜25重I實%
を食合するエアゾール組成物が、
(a)ハウジング下孔の径03〜1.6mm(b)ハウ
ジングのベーパータップ(通気孔)の径0.3〜0.8
+am
(C)ステム孔は2個以下でその径が02〜06ta*
(d)ボタン噴孔の径0.3〜0.6mmの条件を満足
するバルブを具えたエアゾール容器に内に30〜85容
量%充填されたものである。The aerosol product for human body application of the present invention has: 1 to 3 carbon atoms;
Alcohol 55% by weight or less ■ Vapor pressure is 0 at 20°C
.. An aerosol composition that absorbs 8 to 5 kg/amNG of liquefied gas 45 to 95% by weight ■ Carbon dioxide gas 0.2 to 25% by weight (a) The diameter of the lower hole of the housing is 03 to 1.6 mm (b ) Vapor tap (ventilation hole) diameter of housing 0.3 to 0.8
+am (C) There are no more than 2 stem holes with a diameter of 02~06ta* (d) An aerosol container equipped with a valve that satisfies the condition of button nozzle hole diameter of 0.3~0.6mm. % filled by volume.
前記炭素数1〜3個のアルコール類(以下、アルコール
と略称する)の具体例としては、例えばメチルアルコー
ル、エチルアルコール、プロピルアルコール、イソプロ
ピルアルコールおよび変性アルコール等を挙げることか
できる。炭素数4以上のアルコールは沸点が高く気化力
か少ないので、炭素数4以上のものを用いると清涼感が
得られなくなる不都合が生じる。Specific examples of the alcohols having 1 to 3 carbon atoms (hereinafter abbreviated as alcohol) include methyl alcohol, ethyl alcohol, propyl alcohol, isopropyl alcohol, and denatured alcohol. Since alcohols having 4 or more carbon atoms have a high boiling point and low vaporizing power, the use of alcohols with 4 or more carbon atoms may cause the disadvantage that a refreshing sensation cannot be obtained.
このアルコールの配合量は、製品の用途によって異なり
、また同一用途の製品では炭酸ガスの配合量と共に増減
されるが、通常55重潰%以下であることが望ましい。The amount of alcohol blended varies depending on the use of the product, and increases or decreases with the amount of carbon dioxide gas blended in products for the same use, but it is usually desirably 55% by weight or less.
このアルコールの配合が55重量%を越えると、べたつ
きが感じられるという不都合が生じる。またこのアルコ
ールの配合が2重量%より少ないと、清涼感が得られな
いという不都合が生じる。If the alcohol content exceeds 55% by weight, there will be an inconvenience that the product will feel sticky. Furthermore, if the alcohol content is less than 2% by weight, there will be an inconvenience that a refreshing feeling cannot be obtained.
前記液化ガスとしては噴射剤として働くもので、20℃
で蒸気圧0 、8 kg/ cm” G以上5kg/c
m2G以下、特に1.0〜3.5kg/cm2G程度の
ものを用いるのが好ま(7い。ガス圧がこの範囲を超え
ろ液化ガスを用いた場合には、噴霧粒子が細かくなりず
ぎて飛散し易くなる。また、ガス圧がこの範囲に1しな
い場合には、エアゾール組成物の残量か減少したとき所
望の噴霧状態が得られなくなる恐れがある。この液化ガ
スの具体例としては、クロロフルオロカーボン(フロン
)、ジメチルエーテル、炭化水素、液化石油ガスおよび
それらの混合物を挙げることかできる。The liquefied gas acts as a propellant, and at 20°C
At vapor pressure 0, 8 kg/cm” G or more 5 kg/c
It is preferable to use less than m2G, especially about 1.0 to 3.5 kg/cm2G (7.0).If the gas pressure exceeds this range and a filtrated liquefied gas is used, the spray particles will not become too fine and may scatter. In addition, if the gas pressure is not within this range, there is a risk that the desired spray state may not be obtained when the remaining amount of the aerosol composition decreases.Specific examples of this liquefied gas include chloro Mention may be made of fluorocarbons (fluorocarbons), dimethyl ether, hydrocarbons, liquefied petroleum gas and mixtures thereof.
この液化ガスの配合量は、エアゾール組成物全体の45
重哨%以上、95重量%以下であることか望まl、い。The amount of this liquefied gas is 45% of the total aerosol composition.
It is desirable that the weight be at least 95% by weight and not more than 95% by weight.
この高価な液化ガスの配合量を削減し、安価な製品を得
ることおよび製品を特徴づける何効成分等をすることか
らも、液化ガスの配合量かこの範囲を越えることは好ま
しくない。また配合量かこの範囲に達しない場合は、常
に一定した噴霧性状が得られなかったり、液…の破砕力
が弱くなり噴霧粒子を細かく均一にできなくなるという
不都合が生じる。It is not preferable for the amount of liquefied gas to exceed this range in order to reduce the amount of this expensive liquefied gas to obtain an inexpensive product and to add some effective ingredients to characterize the product. In addition, if the blending amount does not reach this range, there will be problems such as not being able to always obtain constant spray properties, or the crushing force of the liquid becoming weak, making it impossible to make the spray particles fine and uniform.
前記炭酸ガスは噴射剤として働くもので、その配合量は
エアゾール組成物全体の0.2〜4重量%に設定される
。炭酸ガスが0.2重量%未満の場合は、容器の内圧を
上げる効果が不十分で、液化ガスの使用量の削減が難し
い。また4重量%を越えると容器内圧が高くなりすぎて
好ましくない。The carbon dioxide gas acts as a propellant, and its amount is set at 0.2 to 4% by weight of the entire aerosol composition. If the carbon dioxide content is less than 0.2% by weight, the effect of increasing the internal pressure of the container is insufficient and it is difficult to reduce the amount of liquefied gas used. Moreover, if it exceeds 4% by weight, the internal pressure of the container becomes too high, which is not preferable.
上記エアゾール組成物には、薬効成分等の経皮吸収を向
上させたりエアゾールの燃焼性を抑えるために、必要に
応じて有効成分の一部として水を配合する。この場合、
配合量はエアゾール組成物全体に対して15重量%以下
に制限されることが望ましい。水が15%を越えて配合
されると、エアゾール組成物を塗布した時べたつきを感
じ、清涼感が損なわれる不都合がある。The aerosol composition may contain water as part of the active ingredients, if necessary, in order to improve transdermal absorption of medicinal ingredients and suppress the flammability of the aerosol. in this case,
It is desirable that the amount incorporated is limited to 15% by weight or less based on the entire aerosol composition. If the water content exceeds 15%, the aerosol composition will feel sticky when applied, and the refreshing sensation will be impaired.
このエアゾール組成物には、前記成分の他に、エアゾー
ル製品の目的を達成するための有効成分等が配合される
。In addition to the above-mentioned components, this aerosol composition contains other active ingredients for achieving the purpose of the aerosol product.
例えば、有効成分としては、エアゾール製品が制汗を目
的とするものであれば粉体を含む制汗成分、消臭成分、
芳香成分などが配合される。またエアゾール製品が消炎
鎮痛を目的とするものであれば、有効成分として抗炎成
分、鎮痛成分などが配合される。人体塗布用のエアゾー
ル製品の場合、通常、有効成分は組成物中に0.1〜1
0重重%程度配合される。For example, if the aerosol product is for antiperspirant purposes, the active ingredients may include antiperspirant ingredients containing powder, deodorizing ingredients,
Contains aromatic ingredients. Furthermore, if the aerosol product is intended for anti-inflammatory and analgesic treatment, anti-inflammatory ingredients, analgesic ingredients, etc. are added as active ingredients. In the case of aerosol products for human application, the active ingredient is usually present in the composition between 0.1 and 1
It is blended at about 0% by weight.
エアゾール組成物には、さらに溶剤、展着剤、酸化防止
剤、乳化剤、懸濁剤、着香剤など一般に使用される成分
も配合される。前記溶剤の具体例としては、アセトン、
メチルエチヶトン等のケトン類、エチルエーテル等のエ
ーテル類、酢酸ブチル、酢酸アミル等のエステル類、ベ
ンゼン、トルエン、キシレン等の芳香族炭化水素、グリ
セリン、プロピレングリコール等の多価アルコール、ク
ロロセン、塩化エチレン等の塩化炭化水素類、ケロシン
等の炭化水素類等を挙げることができる。また粉体を展
着分散させる展着剤としてはミリスチン酸イソプロピル
を、酸化防止剤としてはジブチルヒドロキシアニソール
、ジブチルヒドロキシトルエン、カルボキシメチルセル
ロースやカーボボール等の高分子化合物を、また乳化剤
、静間分散剤としては各種界面活性剤を例示できる。The aerosol composition further contains commonly used components such as a solvent, a spreading agent, an antioxidant, an emulsifier, a suspending agent, and a flavoring agent. Specific examples of the solvent include acetone,
Ketones such as methyl ethicatone, ethers such as ethyl ether, esters such as butyl acetate and amyl acetate, aromatic hydrocarbons such as benzene, toluene, xylene, polyhydric alcohols such as glycerin and propylene glycol, chlorocene, ethylene chloride, etc. Hydrocarbons such as chlorinated hydrocarbons, kerosene, etc. can be mentioned. In addition, isopropyl myristate is used as a spreading agent for spreading and dispersing the powder, polymeric compounds such as dibutylhydroxyanisole, dibutylhydroxytoluene, carboxymethylcellulose, and carbobol are used as antioxidants, and emulsifiers and static dispersants are used. can be exemplified by various surfactants.
次に本発明のエアゾール製品を構成するエアゾール容器
の一般的な構造を第1図に示す。このエアゾール容器は
、容器本体lとパルプ2とによって構成されている。図
中符号3はハウジング下孔、符号4はハウジングのベー
パータップ(通fi 孔)、符号5はステム孔、符号ら
はボタン噴孔である。Next, FIG. 1 shows the general structure of an aerosol container constituting the aerosol product of the present invention. This aerosol container is composed of a container body 1 and a pulp 2. In the figure, numeral 3 is a lower hole in the housing, numeral 4 is a vapor tap (through hole) of the housing, numeral 5 is a stem hole, and numerals are button nozzle holes.
本発明で用いられるエアゾール容器のハウジング下孔3
の直径はt)、311n以上、1.6mm以下に設定さ
れ、ハウジングのベーパータップ4の直径は0.31以
上、0.8ml以下に設定され、ステム孔5は2g以下
にかつその直径は0.2mm以上、06IIl1m以下
に設定され、さらにボタン噴孔6の直径は0,3■以上
、0.6mIm以下に設定される。Lower housing hole 3 of the aerosol container used in the present invention
The diameter of the vapor tap 4 of the housing is set to 0.31 or more and 0.8ml or less, and the diameter of the stem hole 5 is 2g or less and its diameter is 0. The diameter of the button nozzle hole 6 is set to 0.2 mm or more and 0.6 m Im or less, and the diameter of the button nozzle hole 6 is set to 0.3 mm or more and 0.6 m Im or less.
番孔の直径が上記の範囲から外れると、上記エアゾール
組成物が泡状や液状に噴射されたり、細かくなり過ぎて
周囲に拡散してしまう不都合が生じる。If the diameter of the hole deviates from the above range, the aerosol composition may be sprayed in the form of foam or liquid, or become too fine and disperse into the surrounding area.
従来のエアゾール製品では、エアゾール組成物を容器内
容積の85〜90%の充填していたが、本発明のエアゾ
ール製品ではエアゾール組成物の充填量がエアゾール容
器内容積の30容量%以上、85容量%以下に設定され
ている。In conventional aerosol products, the aerosol composition is filled to 85 to 90% of the internal volume of the container, but in the aerosol product of the present invention, the amount of the aerosol composition filled is 30% or more of the internal volume of the aerosol container, which is 85% by volume. % or less.
エアゾール組成物の充填量が前記範囲を越えると、残余
空間が少なくなりすぎて、エアゾール組成物の残量が減
少したときの圧力低下が著しく、噴霧状聾が大幅に変化
する恐れがある。また充填量が前記範囲より低下すると
、はぼ一定に想定されている製品1缶当りの使用回数を
保証できなくなる゛恐れがあるうえ、有効成分の分散性
・溶解性を損なう恐れがある。When the filling amount of the aerosol composition exceeds the above range, the remaining space becomes too small, and when the remaining amount of the aerosol composition decreases, the pressure decreases significantly, and there is a possibility that the atomized deafness will change significantly. Furthermore, if the filling amount is lower than the above range, there is a risk that the number of uses per can of the product, which is assumed to be approximately constant, cannot be guaranteed, and the dispersibility and solubility of the active ingredient may be impaired.
本発明に係る人体塗布エアゾール製品は、従来のエアゾ
ール製品と同様の方法で製造できる。即ち有効成分とア
ルコールを配合、調製し、これをエアゾール容器に入れ
た後、噴射剤としての液化ガスと炭酸ガスの充填するこ
とによって製造できる。噴射剤としての液化ガスと炭酸
ガスの充填方法に特に制限はない。例えば炭酸ガスの充
填方法としては、有効成分とアルコールとの混合液に先
ず液化ガスを充填し一定圧力で炭酸ガスを送入すると共
に振とう、して炭酸ガスを吸収させる振とう式、吸収を
早めるために送入ガスの圧力を高くした高圧式、低温で
行なう冷却式、予め炭酸ガスを混合液に飽和混合させる
飽和式等がある。The human body application aerosol product according to the present invention can be manufactured in the same manner as conventional aerosol products. That is, it can be produced by blending and preparing the active ingredient and alcohol, placing this in an aerosol container, and then filling it with liquefied gas and carbon dioxide gas as propellants. There are no particular limitations on the method of filling the liquefied gas and carbon dioxide gas as propellants. For example, methods for filling carbon dioxide gas include a shaking method, in which a mixture of active ingredients and alcohol is first filled with liquefied gas, carbon dioxide gas is introduced at a constant pressure, and the carbon dioxide is absorbed by shaking. There is a high-pressure type in which the pressure of the gas to be supplied is increased to speed up the process, a cooling type in which the process is carried out at a low temperature, and a saturation type in which carbon dioxide is mixed into the liquid mixture in advance to saturation.
なお本発明の人体塗布用エアゾール製品は、制汗剤、外
用鎮痛消炎剤、害虫忌避剤、消毒剤、水虫治療剤など各
分野に適用できる。The aerosol product for human body application of the present invention can be applied to various fields such as antiperspirants, external analgesic and antiinflammatory agents, pest repellents, disinfectants, and athlete's foot treatment agents.
本発明のエアゾール製品を構成するエアゾール組成物に
配合されたアルコールは、揮発性を有しているので、そ
の蒸気圧により噴射圧力の一部を補う。またアルコール
は塗布された体表で気化するので清涼感を与えることか
できる。またアルコールは有効成分を溶かす溶剤として
も働く。Since the alcohol blended into the aerosol composition constituting the aerosol product of the present invention has volatility, part of the injection pressure is compensated for by its vapor pressure. Additionally, since alcohol evaporates on the body surface to which it is applied, it can provide a cooling sensation. Alcohol also acts as a solvent to dissolve the active ingredients.
またエアゾール組成物には炭酸ガスが配合されているの
で、炭酸ガスによって噴射圧力の一部が補われ、液化ガ
スの使用量を減らすことができる。Furthermore, since the aerosol composition contains carbon dioxide gas, part of the injection pressure is compensated for by the carbon dioxide gas, making it possible to reduce the amount of liquefied gas used.
そして本発明のエアゾール製品では、前述の組成を有す
るエアゾール組成物を、前述の条件を満たすバルブを備
えたエアゾール容器に充填したので、より優れたエアゾ
ール噴霧性能を発揮し、人体に好適に使用することがで
きる。In the aerosol product of the present invention, the aerosol composition having the above-mentioned composition is filled into an aerosol container equipped with a valve that satisfies the above-mentioned conditions, so it exhibits better aerosol spray performance and is suitable for use on the human body. be able to.
また請求項2記載のエアゾール製品においては、水が配
合されているので、燃焼性が低くかつ有効成分の経皮吸
収性に優れたものとなる。Furthermore, since the aerosol product according to claim 2 contains water, it has low flammability and excellent percutaneous absorption of the active ingredient.
(実施例I)
第1表に示す組成および容器構成からなるエアゾール製
品を作成して、使用感と噴射状態を調べた。この実施例
で用いた容器の中、比6.比7.実6、実7のものは、
2個のステム孔を有するものである。なお第1表中比較
例1と比較例6は従来品である。(Example I) Aerosol products having the compositions and container configurations shown in Table 1 were prepared, and the usability and spraying conditions were examined. In the container used in this example, ratio 6. Ratio 7. Fruit 6 and fruit 7 are
It has two stem holes. Note that Comparative Example 1 and Comparative Example 6 in Table 1 are conventional products.
評価方法
■)使用感
各エアゾール製品を男女10名の前腕部に1Oct1の
距離から3秒間噴射して、清涼感、へたつきを評価して
もらった。Evaluation method ■) Feeling of use Each aerosol product was sprayed onto the forearms of 10 men and women for 3 seconds from a distance of 1 Oct 1, and they were asked to evaluate the coolness and stiffness.
2)噴射状態
各エアゾール製品を使用感を調べたときと同様に5秒間
噴射し、噴射中の噴霧粒子の大きさと舞い上がり状態を
観察した。2) Spraying condition Each aerosol product was sprayed for 5 seconds in the same manner as when examining the feeling of use, and the size and flying state of the spray particles during spraying were observed.
これらの結果を第1表のように評価した。結果を第2表
に示す。These results were evaluated as shown in Table 1. The results are shown in Table 2.
以下余白 評価 第2表 第1表に示す結果から、以下のことが判る。Margin below evaluation Table 2 From the results shown in Table 1, the following can be seen.
■ 実施例1,2.3と比較例1とを比較すると、従来
品である比較例1では48g〔・80gX(26,4+
264+7.2)%〕配合する必要のあった液化ガスを
、炭酸ガスが0164〜2.24g添加された実施例の
ものでは37.44g(・64gx(25,8+25゜
8+6.9)%〕に削減しても良好な使用感および噴霧
状態を得ることが判った。■ Comparing Examples 1, 2.3 and Comparative Example 1, Comparative Example 1, which is a conventional product, weighs 48g[・80gX(26,4+
264 + 7.2)%] The liquefied gas that needed to be blended was reduced to 37.44g (・64g It was found that even if the amount was reduced, a good feeling of use and a good spray condition could be obtained.
■ アルコールの配合されていない従来品である比較例
6に対して、炭酸ガスを添加して液化ガスの配合を減ら
した比較例7のものは、噴霧状態は良好に保たれている
もののドライ感が加わり、清涼感が薄らいだものになる
が、実施例6のようにアルコールを加えると清涼感が改
善されることが判った。■ Compared to Comparative Example 6, which is a conventional product that does not contain alcohol, Comparative Example 7, which added carbon dioxide to reduce the amount of liquefied gas, maintains a good spray condition but has a dry feel. However, it was found that adding alcohol as in Example 6 improved the refreshing feeling.
■ 実施例4および比較例2はエタノールの配合量を検
討した結果である、これらを比較すると有効成分とアル
コールとの混合物の配合量が55%を超えると、ややべ
たつき感が生じて使用感が悪化することが判る。■ Example 4 and Comparative Example 2 are the results of examining the blending amount of ethanol. Comparing these results, when the blending amount of the mixture of active ingredient and alcohol exceeds 55%, a slightly sticky feeling occurs and the feeling of use is poor. I know it's going to get worse.
■ 比較例3、比較例4はエアゾール容器のバルブ径を
かえて、使用感、噴霧状態をみたものであるが、あまり
径の小さいものを使用すると、霧が細かくなり過ぎる。(2) In Comparative Examples 3 and 4, the valve diameter of the aerosol container was changed and the feeling of use and spray condition were observed. If a container with a too small diameter is used, the mist becomes too fine.
また径が大きすぎると、霧が粗くなり、塗布量は確保出
来るがべたつきが感じられるようになることが判る。Furthermore, if the diameter is too large, the mist will become coarse and the amount of application can be secured, but it will feel sticky.
■ 実施例5、比較例5は水の添加量を検討したもので
ある。これらを比較すると水の添加量が約15重量%を
超えるとべたつきが感じられて使用感が悪化することが
判る。(2) In Example 5 and Comparative Example 5, the amount of water added was investigated. Comparing these results, it can be seen that when the amount of water added exceeds about 15% by weight, stickiness is felt and the feeling of use deteriorates.
■ また実施例1〜実施例4と従来品である比較例1、
および実施例6と従来品である比較例6を比較すると、
0.064gの殺菌剤または1.6gの制汗剤を充填す
るためには、従来品では組成物を80g充填しなければ
ならないのに対して、実施例では64gの充填で良く、
製品を軽量化できることが判明した。このように実施例
のものが充填量を低減できたのは、配合されたアルコー
ルが溶剤としても働くためである。■ In addition, Examples 1 to 4 and Comparative Example 1, which is a conventional product,
Comparing Example 6 and Comparative Example 6, which is a conventional product,
In order to fill 0.064 g of disinfectant or 1.6 g of antiperspirant, the conventional product must be filled with 80 g of the composition, whereas in the example, 64 g of the composition is sufficient.
It was found that the weight of the product could be reduced. The reason why the filling amount was able to be reduced in the examples is that the blended alcohol also acts as a solvent.
次に実施例のものを低温下(5℃)で噴射して、噴射状
態を調べた。その結果、実施例のエアゾール製品は低温
下でも、微細な霧状で噴射可能であることが判った。Next, the examples were sprayed at low temperature (5° C.) and the spraying conditions were examined. As a result, it was found that the aerosol products of Examples could be sprayed in the form of fine mist even at low temperatures.
ついで実施例のエアゾール製品を構成するエアゾール容
器を倒立状態で噴霧したところ、噴霧状態は正立状態と
同じで、炭酸ガスのみが噴射されるような事態は生じな
かった。これは容器のバルブにベーパータップが設けら
れているためである。Next, when the aerosol container constituting the aerosol product of the example was sprayed in an inverted state, the spray state was the same as in the upright state, and no situation where only carbon dioxide gas was sprayed occurred. This is because the valve of the container is equipped with a vapor tap.
(実施例■)
第1表に示した実施例1のエアゾール製品と、炭酸ガス
に代えて窒素ガスを用いた点のみ実施例1と異なるエア
ゾール製品(比較例8)とを準備し、噴射回数と噴射量
との関係を調べた。なお比較例8の窒素充填量は、実施
例1のものとほぼ同じ初期圧力が得られるように設定さ
れている。結果を第2図に示す。(Example ■) The aerosol product of Example 1 shown in Table 1 and an aerosol product (Comparative Example 8) that differs from Example 1 only in that nitrogen gas was used instead of carbon dioxide gas were prepared, and the number of injections was The relationship between this and the injection amount was investigated. Note that the amount of nitrogen filling in Comparative Example 8 was set so as to obtain almost the same initial pressure as that in Example 1. The results are shown in Figure 2.
この結果、炭酸ガスを用いた実施例1のエアゾール製品
は、噴射量が安定していることが判明1゜た。As a result, it was found that the aerosol product of Example 1 using carbon dioxide gas had a stable injection amount by 1°.
以上説明したように本発明の人体塗布用エアゾール製品
は、有効成分と炭素数1〜3のアルコールとの混合液、
20℃の蒸気圧が0.8〜5kg/cts2Gの液化ガ
スおよび炭酸ガスとが所定比率で配合されたエアゾール
組成物が、パルプ径が所定の範囲に設定されたエアゾー
ル容器内に30〜85容量%充填されたものなので、清
涼感や噴霧状態を損なうことなく、高価な液化ガスの使
用量を低減できる(従来品の80%以下に低減可能)。As explained above, the aerosol product for human body application of the present invention comprises a liquid mixture of an active ingredient and an alcohol having 1 to 3 carbon atoms;
An aerosol composition containing liquefied gas with a vapor pressure of 0.8 to 5 kg/cts2G at 20°C and carbon dioxide gas in a predetermined ratio is placed in an aerosol container with a pulp diameter of 30 to 85 volumes in a predetermined range. % filling, it is possible to reduce the amount of expensive liquefied gas used (can be reduced to 80% or less compared to conventional products) without compromising the cooling sensation or spray quality.
従って本発明によれば、エアゾール製品の製造コストの
低減を図ることができる。Therefore, according to the present invention, it is possible to reduce the manufacturing cost of aerosol products.
また本発明のエアゾール製品では、配合されたアルコー
ルが有効成分の溶剤としても働くので、有効成分をより
高濃度に配合できる。従って本発明のエアゾール製品で
は、エアゾール組成物の充填量を低減して、軽量化を図
ることができる。またこのエアゾール製品は、必要量の
有効成分を短時間に塗布できるものとなる。Furthermore, in the aerosol product of the present invention, the blended alcohol also acts as a solvent for the active ingredient, so the active ingredient can be blended at a higher concentration. Therefore, in the aerosol product of the present invention, the weight can be reduced by reducing the amount of aerosol composition filled. This aerosol product also allows the required amount of active ingredient to be applied in a short period of time.
また本発明のエアゾール製品によれば、フロン等の環境
を破壊する可能性のある物質の使用量を低減できる。Further, according to the aerosol product of the present invention, it is possible to reduce the amount of substances that may damage the environment, such as fluorocarbons.
圧縮ガスとしては、亜酸化窒素(笑気ガス)、窒素、空
気、ヘリウム、ネオン、アルゴン等があるが、炭酸ガス
は価格、安全性、原液への溶解性等に優れているので、
この炭酸ガスを用いたエアゾール製品は、安価で安全性
に優れ、かつ使用時の前半と後半とで噴射量の変化が少
ないという利点を特徴する
請求項2のエアゾール製品は、15重重%以下の水が配
合されたものなので、優れた経皮吸収性を有すると共に
、燃焼しにくく安全性の高いものとなる。Compressed gases include nitrous oxide (laughing gas), nitrogen, air, helium, neon, argon, etc., but carbon dioxide gas is superior in terms of price, safety, solubility in stock solutions, etc.
This aerosol product using carbon dioxide gas is inexpensive, has excellent safety, and has the advantage that there is little change in injection amount between the first half and the second half of use. Since it contains water, it has excellent transdermal absorption and is resistant to combustion and highly safe.
第1図は本発明のエアゾール製品を構成するエアゾール
容器の一例を示す断面図、第2図は実施例■の結果を示
すグラフである。
l・・・・・・容器本体、2・・・バルブ、3・・・ハ
ウジング下孔、4・・・ハウジングのベーパータップ孔
、5・・ステム孔、6・・・ボタン噴孔。FIG. 1 is a sectional view showing an example of an aerosol container constituting the aerosol product of the present invention, and FIG. 2 is a graph showing the results of Example 2. l... Container body, 2... Valve, 3... Lower housing hole, 4... Vapor tap hole of housing, 5... Stem hole, 6... Button nozzle hole.
Claims (2)
容器とからなる人体塗布用エアゾール製品であって、 前記エアゾール組成物が [1]炭素数1〜3のアルコール55重量%以下 [2]20℃における蒸気圧が0.8〜5kg/cm^
2Gの液化ガス45〜95重量% [3]炭酸ガス0.2〜2.5重量% を含有する組成物であり、 前記エアゾール容器が (a)ハウジング下孔の径0.3〜1.6mm (b)ハウジングのベーパータップの径0.3〜0.8
mm (c)ステム孔は2個以下でその径が0.2〜0.6m
m (d)ボタン噴孔の径0.3〜0.6mm の条件を満足するバルブを具えたものであり、かつ該エ
アゾール容器内に前記エアゾール組成物が30〜85容
量%充填されていることを特徴とする人体塗布用エアゾ
ール製品。(1) An aerosol product for human body application comprising an aerosol composition and an aerosol container containing the aerosol composition, wherein the aerosol composition contains [1] 55% by weight or less of alcohol having 1 to 3 carbon atoms [2] 20°C The vapor pressure at is 0.8~5kg/cm^
2G liquefied gas 45 to 95% by weight; [3] carbon dioxide gas 0.2 to 2.5% by weight; (b) Vapor tap diameter of housing 0.3 to 0.8
mm (c) No more than 2 stem holes with a diameter of 0.2 to 0.6 m
(d) The aerosol container is equipped with a valve that satisfies the condition that the diameter of the button nozzle hole is 0.3 to 0.6 mm, and the aerosol container is filled with 30 to 85% by volume of the aerosol composition. An aerosol product for human body application featuring:
重量%以下配合されたとを特徴とする請求項1記載の人
体塗布用エアゾール製品。(2) Water as an active ingredient in the aerosol composition is 15%
2. The aerosol product for application to the human body according to claim 1, wherein the aerosol product contains less than % by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1093395A JP2642738B2 (en) | 1989-04-13 | 1989-04-13 | Aerosol products for human body application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1093395A JP2642738B2 (en) | 1989-04-13 | 1989-04-13 | Aerosol products for human body application |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02272084A true JPH02272084A (en) | 1990-11-06 |
JP2642738B2 JP2642738B2 (en) | 1997-08-20 |
Family
ID=14081114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1093395A Expired - Fee Related JP2642738B2 (en) | 1989-04-13 | 1989-04-13 | Aerosol products for human body application |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2642738B2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02294382A (en) * | 1989-05-09 | 1990-12-05 | Kao Corp | Aerosol product |
JP2001172616A (en) * | 1999-12-20 | 2001-06-26 | Kyowa Industrial Co Ltd | Whole quantity-jetting type aerosol product |
US7160538B2 (en) | 1990-02-03 | 2007-01-09 | Boehringer Ingelheim Kg | Suspension aerosol formulations of pharmaceutical products |
FR2903889A1 (en) * | 2006-07-19 | 2008-01-25 | Jean Abeya | Perfumed liquid composition containing dissolved carbon dioxide for applying on the skin |
US8187574B2 (en) | 2000-04-17 | 2012-05-29 | Dazio Corporation | Intermittent injection aerosol product for skin |
JP2013060442A (en) * | 1999-01-19 | 2013-04-04 | Earth Chemical Co Ltd | Spray product for air conditioner |
GB2528284A (en) * | 2014-07-16 | 2016-01-20 | Mcbride Robert Ltd | Spray device |
JP2018070170A (en) * | 2016-10-24 | 2018-05-10 | 株式会社ダイゾー | Aerosol product for space |
-
1989
- 1989-04-13 JP JP1093395A patent/JP2642738B2/en not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02294382A (en) * | 1989-05-09 | 1990-12-05 | Kao Corp | Aerosol product |
US7160538B2 (en) | 1990-02-03 | 2007-01-09 | Boehringer Ingelheim Kg | Suspension aerosol formulations of pharmaceutical products |
JP2013060442A (en) * | 1999-01-19 | 2013-04-04 | Earth Chemical Co Ltd | Spray product for air conditioner |
JP2001172616A (en) * | 1999-12-20 | 2001-06-26 | Kyowa Industrial Co Ltd | Whole quantity-jetting type aerosol product |
US8187574B2 (en) | 2000-04-17 | 2012-05-29 | Dazio Corporation | Intermittent injection aerosol product for skin |
FR2903889A1 (en) * | 2006-07-19 | 2008-01-25 | Jean Abeya | Perfumed liquid composition containing dissolved carbon dioxide for applying on the skin |
GB2528284A (en) * | 2014-07-16 | 2016-01-20 | Mcbride Robert Ltd | Spray device |
JP2018070170A (en) * | 2016-10-24 | 2018-05-10 | 株式会社ダイゾー | Aerosol product for space |
Also Published As
Publication number | Publication date |
---|---|
JP2642738B2 (en) | 1997-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5620631A (en) | Pressurized-gas pack and propellant for aerosols | |
US5182097A (en) | Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content | |
US5190029A (en) | Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content | |
US5397564A (en) | Aerosol preparation for external use | |
JPH02272084A (en) | Aerosol product for application to human body | |
US5976504A (en) | Topical aerosol formulation for cooling of mammalian tissues | |
JPS6254784A (en) | Aerosol composition | |
JP2729244B2 (en) | Aerosol products | |
JP2898316B2 (en) | Eazole products for human body | |
JPH0313275B2 (en) | ||
JPH11100308A (en) | Cosmetic making cracking sound | |
JP2540536B2 (en) | Azol type external application agent | |
JP2000119132A (en) | Aerosol composition | |
JP3055890B2 (en) | Valves used for human body aerosol products | |
JPS63141917A (en) | Aerosol composition for hair-tonic | |
JPH0120131B2 (en) | ||
JP2634858B2 (en) | Fast-breaking foamed aerosol composition | |
JP2795354B2 (en) | Aerosol products for human body | |
JPH04273807A (en) | Rapidly foam-breaking aerosol type cosmetic composition | |
JP3934193B2 (en) | Pest repellent aerosol | |
JPH0224382A (en) | Aerosol composition | |
JPH04189365A (en) | Aerosol container | |
JP2000086499A (en) | Aerosol composition for forming foam | |
US11427741B2 (en) | Cryogenic, kinetically active formulations and systems for their dispensing | |
KR100532691B1 (en) | The cosmetic product and its manufacturing method of UV-protection having the ice sherbet-shape |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |